Comparison of the cardiac effects of ASI 222 HCl, an aminosugar cardiac glycoside, and digoxin

L. S. Cook, Robert William Caldwell, C. B. Nash

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The effects of ASI-222 HCl and digoxin on cardiac contractile force, dP/dt, heart rate and mean blood pressure in the dog were evaluated following i.v. administration. Additional studies were performed on isolated, electrically driven rabbit atria with both ASI-222 and digoxin. Our data show that ASI-222 (40 μg/kg) in non-vagotomized dogs produced a two-fold greater increase in cardiac contractile force and dP/dt than did an equimolar dose of digoxin. ASI-222 caused a peak increase in contractile force and dP/dt 10 min after administration, whereas the peak to digoxin occurred at 30 min. ASI-222 was more effective in non-vagotomized dogs in increasing contractile force and dP/dt than in vagotomized dogs. The inotropic responses to digoxin were not reduced by vagotomy. Studies on isolated electrically driven rabbit atria indicate ASI-222 to be 7-8 times more potent than digoxin in increasing contractile force. These data demonstrate that ASI-222 produces an earlier and greater increase in contractile force and dP/dt than digoxin in equimolar doses.

Original languageEnglish (US)
Pages (from-to)220-232
Number of pages13
JournalArchives Internationales de Pharmacodynamie et de Therapie
Volume227
Issue number2
StatePublished - Dec 1 1977
Externally publishedYes

Fingerprint

Cardiac Glycosides
Digoxin
Dogs
Rabbits
Vagotomy
ASI-222
Heart Rate
Blood Pressure

ASJC Scopus subject areas

  • Pharmacology

Cite this

Comparison of the cardiac effects of ASI 222 HCl, an aminosugar cardiac glycoside, and digoxin. / Cook, L. S.; Caldwell, Robert William; Nash, C. B.

In: Archives Internationales de Pharmacodynamie et de Therapie, Vol. 227, No. 2, 01.12.1977, p. 220-232.

Research output: Contribution to journalArticle

@article{190f43dd60ca47fb98931d1db3c43bd0,
title = "Comparison of the cardiac effects of ASI 222 HCl, an aminosugar cardiac glycoside, and digoxin",
abstract = "The effects of ASI-222 HCl and digoxin on cardiac contractile force, dP/dt, heart rate and mean blood pressure in the dog were evaluated following i.v. administration. Additional studies were performed on isolated, electrically driven rabbit atria with both ASI-222 and digoxin. Our data show that ASI-222 (40 μg/kg) in non-vagotomized dogs produced a two-fold greater increase in cardiac contractile force and dP/dt than did an equimolar dose of digoxin. ASI-222 caused a peak increase in contractile force and dP/dt 10 min after administration, whereas the peak to digoxin occurred at 30 min. ASI-222 was more effective in non-vagotomized dogs in increasing contractile force and dP/dt than in vagotomized dogs. The inotropic responses to digoxin were not reduced by vagotomy. Studies on isolated electrically driven rabbit atria indicate ASI-222 to be 7-8 times more potent than digoxin in increasing contractile force. These data demonstrate that ASI-222 produces an earlier and greater increase in contractile force and dP/dt than digoxin in equimolar doses.",
author = "Cook, {L. S.} and Caldwell, {Robert William} and Nash, {C. B.}",
year = "1977",
month = "12",
day = "1",
language = "English (US)",
volume = "227",
pages = "220--232",
journal = "Archives Internationales de Pharmacodynamie et de Therapie",
issn = "0003-9780",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Comparison of the cardiac effects of ASI 222 HCl, an aminosugar cardiac glycoside, and digoxin

AU - Cook, L. S.

AU - Caldwell, Robert William

AU - Nash, C. B.

PY - 1977/12/1

Y1 - 1977/12/1

N2 - The effects of ASI-222 HCl and digoxin on cardiac contractile force, dP/dt, heart rate and mean blood pressure in the dog were evaluated following i.v. administration. Additional studies were performed on isolated, electrically driven rabbit atria with both ASI-222 and digoxin. Our data show that ASI-222 (40 μg/kg) in non-vagotomized dogs produced a two-fold greater increase in cardiac contractile force and dP/dt than did an equimolar dose of digoxin. ASI-222 caused a peak increase in contractile force and dP/dt 10 min after administration, whereas the peak to digoxin occurred at 30 min. ASI-222 was more effective in non-vagotomized dogs in increasing contractile force and dP/dt than in vagotomized dogs. The inotropic responses to digoxin were not reduced by vagotomy. Studies on isolated electrically driven rabbit atria indicate ASI-222 to be 7-8 times more potent than digoxin in increasing contractile force. These data demonstrate that ASI-222 produces an earlier and greater increase in contractile force and dP/dt than digoxin in equimolar doses.

AB - The effects of ASI-222 HCl and digoxin on cardiac contractile force, dP/dt, heart rate and mean blood pressure in the dog were evaluated following i.v. administration. Additional studies were performed on isolated, electrically driven rabbit atria with both ASI-222 and digoxin. Our data show that ASI-222 (40 μg/kg) in non-vagotomized dogs produced a two-fold greater increase in cardiac contractile force and dP/dt than did an equimolar dose of digoxin. ASI-222 caused a peak increase in contractile force and dP/dt 10 min after administration, whereas the peak to digoxin occurred at 30 min. ASI-222 was more effective in non-vagotomized dogs in increasing contractile force and dP/dt than in vagotomized dogs. The inotropic responses to digoxin were not reduced by vagotomy. Studies on isolated electrically driven rabbit atria indicate ASI-222 to be 7-8 times more potent than digoxin in increasing contractile force. These data demonstrate that ASI-222 produces an earlier and greater increase in contractile force and dP/dt than digoxin in equimolar doses.

UR - http://www.scopus.com/inward/record.url?scp=0017739707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017739707&partnerID=8YFLogxK

M3 - Article

C2 - 907408

AN - SCOPUS:0017739707

VL - 227

SP - 220

EP - 232

JO - Archives Internationales de Pharmacodynamie et de Therapie

JF - Archives Internationales de Pharmacodynamie et de Therapie

SN - 0003-9780

IS - 2

ER -